Thomas Clozel is a visionary entrepreneur and oncologist, very French, co-founder of Owkin and Bioptimus. As CEO of Owkin, he is pioneering the future of agentic next gen pharma. By bridging cutting-edge AI with biological science, Owkin is accelerating breakthroughs that redefine how we develop and deliver new treatments for every patient.